(2S,3R)-N-[1-(3,5-di-tert-butyl-4-hydroxybenzoyl)-2-methylazetidin-3-yl]-2,2,2-trifluoroacetamide

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (2S,3R)-N-[1-(3,5-di-tert-butyl-4-hydroxybenzoyl)-2-methylazetidin-3-yl]-2,2,2-trifluoroacetamide
• 英文别名: N-[1-(3,5-di-tert-butyl-4-hydroxy-benzoyl)-(2S,3R)-2-methyl-azetidin-3-yl]-2,2,2-trifluoro-acetamide；N-[(2S,3R)-1-(3,5-ditert-butyl-4-hydroxybenzoyl)-2-methylazetidin-3-yl]-2,2,2-trifluoroacetamide
• 化学式: C₂₁H₂₉F₃N₂O₃
• 分子量: 414.468
• InChiKey: BNZPKCFIUDQGQG-XHDPSFHLSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.1
• 重原子数：
  29
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.62
• 拓扑面积：
  69.6
• 氢给体数：
  2
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  (2S,3R)-2,2,2-trifluoro-N-(2-methyl-azetidin-3-yl)-acetamide hydrochloride 、 3,5-di-tert-butyl-4-hydroxybenzoyl chloride 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 0.17h， 以80%的产率得到(2S,3R)-N-[1-(3,5-di-tert-butyl-4-hydroxybenzoyl)-2-methylazetidin-3-yl]-2,2,2-trifluoroacetamide
  参考文献：
  名称：

  Substituted Azetidine compounds, their preparation and use as medicaments

  摘要：

  本发明涉及通用式(I)的取代氮杂环丙烷化合物，其制备方法，包含这些化合物的药物，以及它们用于制备用于治疗人类和动物的药物。

  公开号：

  US20050182041A1

文献信息

• Substituted azetidine compounds as cyclooxygenase-1-cyclooxygenase-2 inhibitors, and their preparation and use as medicaments
  申请人：Cuberes Altisen Rosa

  公开号：US20070093469A1

  公开（公告）日：2007-04-26

  The present invention relates to substituted Azetidine compounds of general formula (I), methods for their preparation, medicaments comprising these compounds as well as their use for the preparation of a medicament for the treatment of humans and animals.

  本发明涉及通式(I)的取代氮杂环丙烷化合物，其制备方法，包含这些化合物的药物以及它们用于制备用于治疗人类和动物的药物。
• Substituted azetidine compounds, their preparation and use as medicaments
  申请人：Laboratorios de Dr. Esteve S.A.

  公开号：US07232812B2

  公开（公告）日：2007-06-19

  The present invention relates to substituted Azetidine compounds of general formula (I), methods for their preparation, medicaments comprising these compounds as well as their use for the preparation of a medicament for the treatment of humans and animals.

  本发明涉及通式（I）的取代氮杂丙烷化合物、其制备方法、包含这些化合物的药物以及它们用于制备用于治疗人类和动物的药物的用途。
• SUBSTITUTED AZETIDINE COMPOUNDS AS CYCLOOXYGENASE-1 - CYCLOOXYGENASE-2 INHIBITORS, AND THEIR PREPARATION AND USE AS MEDICAMENTS
  申请人：LABORATORIOS DEL DR. ESTEVE, S.A.

  公开号：EP1727793B1

  公开（公告）日：2008-04-09
• US7232812B2
  申请人：——

  公开号：US7232812B2

  公开（公告）日：2007-06-19
• [EN] SUBSTITUTED AZETIDINE COMPOUNDS AS CYCLOOXYGENASE-1-CYCLOOXYGENASE-2 INHIBITORS, AND THEIR PREPARATION AND USE AS MEDICAMENTS<br/>[FR] COMPOSES AZETIDINE SUBSTITUES UTILES COMME INHIBITEURS DE CYCLOOXYGENASE-1-CYCLOOXYGENASE-2 ET LEUR PREPARATION ET UTILISATION COMME MEDICAMENTS
  申请人：ESTEVE LABOR DR

  公开号：WO2005077896A1

  公开（公告）日：2005-08-25

  The present invention relates to substituted Azetidine compounds of general formula (I), methods for their preparation, medicaments comprising these compounds as well as their use for the preparation of a medicament for the treatment of humans and animals.